casino barriere blotzheim:casino,barriere,blotzheim,锘,娈佃:锘? {娈佃惤} {娈佃惤} [Main ingredient] Paroxetine hydrochloride. [Indications / Indications] Paroxetine hydrochloride tablets, indications for the treatment of various types of depression, including anxiety with depression and reacti

casino barriere blotzheim

锘?

{娈佃惤}

{娈佃惤}

[Main ingredient] Paroxetine hydrochloride. [Indications / Indications] Paroxetine hydrochloride tablets, indications for the treatment of various types of depression, including anxiety with depression and reactive depression.

Common depressive symptoms: fatigue, sleep disorders, lack of interest and pleasure in daily activities, loss of appetite.

Treat obsessive-compulsive disorder.

Common obsessive-compulsive symptoms: Feeling repeated and persistent thoughts, impulses, or imaginations that can cause significant anxiety, leading to repetitive behaviors or psychological activities.

Treat panic disorder with or without square horror. Common symptoms of panic attacks: palpitations, sweating, shortness of breath, chest pain, nausea, tingling, and sudden death. Treat social phobia/social anxiety disorder.

Symptoms of common social anxiety: palpitations, sweating, shortness of breath, etc.

Often manifested as a fear of being prominent or persistent in one or more social situations or performances, leading to avoidance. After the treatment is satisfactory, continue to take this product to prevent the recurrence of depression, panic disorder and obsessive-compulsive disorder.

The above information about the side effects of Leyou hydrochloride paroxetine tablets, I hope everyone can understand, in the process of medication, use drugs carefully to ensure their own personal safety. If you want to know more, you can directly visit the Kangzhijia professional pharmacy store, or call the hotline 4008-779-220. Common name: paroxetine hydrochloride tablets English name: ParoxetineHydrochlorideTablets [Properties] This product is a white film-coated tablet, after removing the coating, it is white or white. [Drug name] [Contraindications] It is known that allergic to this product and its excipients is prohibited. This product cannot be combined with a monoamine oxidase inhibitor (including the antibiotic drug linezolid, a reversible, non-selective monoamine kinase inhibitor) or within two weeks of treatment with a monoamine oxidase inhibitor.

Similarly, monoamine oxidase inhibitors should not be used within two weeks after the end of treatment with this product (see [Drug Interactions] for details).

This product cannot be combined with thioridazine. Because it is the same as other drugs that inhibit the liver cytochrome P450 isoenzyme CYP4502D6.

This product can cause an increase in the plasma concentration of thioridazine (see [Drug Interactions]).

The use of thioridazine alone can lead to prolongation of the QTc interval. And accompanied by severe ventricular arrhythmia. For example, an electrocardiogram shows spikes (crests) and sudden death. This product should not be combined with pimozide (see [Drug Interactions]). [Adverse reactions] may have gastrointestinal discomfort, such as nausea, anorexia, diarrhea and so on.

There may also be headaches, restlessness, weakness, lethargy, insomnia and dizziness.

Rare adverse reactions include allergic skin rashes and decreased sexual function. However, drug withdrawal can be seen in withdrawal syndrome, such as insomnia, anxiety, nausea, sweating, dizziness or paresthesia.

See the package instructions for details. [Usage and Dosage] Oral, it is recommended to take the daily breakfast, the whole pill is swallowed and not chewed. Adult: Depression: The general dose is 20 mg per day.

After taking 2-3 weeks, according to the patient's reaction, some patients need to increase the amount, increasing by 10mg per week. According to foreign experience, the maximum daily dose can reach 50mg, and should be prescribed. Obsessive-compulsive disorder: The general dose is 40 mg per day, and the initial dose is 20 mg per day, increasing by 10 mg per week.

According to foreign experience, the maximum daily dose can reach 60mg. Panic disorder: The general dose is 40 mg per day, and the initial dose is 10 mg per day. According to the patient's reaction, the daily dose is increased by 10 mg, and the maximum daily dose is up to 50 mg. It is generally believed that the symptoms may be aggravated in the early stage of treatment of panic disorder, so the initial dose is 10 mg.

Social phobia/social anxiety disorder: The general dose is 20mg per day. If the patient does not respond to 20mg, the patient's clinical response can be increased by 10mg per week. According to foreign experience, the maximum daily dose can reach 50mg.

The dose change is at least one week apart. This product is the same as all antidepressants, and the dosage should be adjusted according to the condition during treatment. The patient should be treated for a sufficient period of time to consolidate the effect. After the depression has healed, the treatment should be maintained for at least several months, and obsessive-compulsive disorder and panic disorder require longer maintenance treatment.

The drug withdrawal method is similar to other psychiatric drugs and needs to be gradually reduced. It is not suitable for sudden withdrawal.

The discontinuation of paroxetine is similar to other psychotropic substances. This product is generally not suitable for sudden withdrawal (see [Precautions] and [Adverse Reactions]).

The gradual reduction protocol used in recent clinical trials is: gradual reduction at weekly intervals, weekly daily doses reduced by 10 mg from last week's daily dose, and reduced once a week. When the daily dose is reduced to 20 mg per day, the patient continues to take the drug for 1 week and then discontinues the drug.

If symptoms of intolerance occur after reduction or withdrawal, consider reverting to the previous dose. The doctor can then proceed with the reduction program, but the rate of reduction is slower. Kidney/liver function impairment: Patients with severe renal impairment (creatinine clearance [30 ml/min) or severe liver damage have higher blood levels than healthy subjects after taking this product.

Therefore, the recommended dose is 20 mg per day. If you need to increase the dose, you should also limit the lower limit of the medication range. The above article introduces us how long it takes for Leo Paroxetine to work. From the above, we understand that it takes a certain amount of time to use this drug, and we can't take it too quickly.

If you increase the dose privately in order to see the effect immediately, you will not only receive the expected effect, but may even harm our health.

Generic name: paroxetine hydrochloride dizziness, sensory disturbances (including paresthesia, electroconvulsive sensation and tinnitus), sleep disorders (including strong dreams), excitement or anxiety, nausea, tremors, confusion, sweating, headache Diarrhea has been reported.

These symptoms are generally mild to moderate, but some patients may have severe symptoms.

These conditions often occur a few days after discontinuation, but it is also rare to report that these symptoms occur in patients who have accidentally missed a drug. These symptoms are generally self-limiting, often within 2 weeks. Regression, although some people's symptoms may be prolonged (2-3 months or longer). Therefore, it is recommended that when this product is deactivated, it should be gradually reduced according to the needs of the patient, in a few weeks or months (see 'Paroxetine withdrawal', usage and dosage). Guide: Leyou (paroxetine hydrochloride tablets) treatment of depression, out of social fear, depression, also known as depression, with a significant and lasting mood as the main clinical features, is the main type of psychological disorders.

Common depressive symptoms: fatigue, sleep disorders, lack of interest and pleasure in daily activities, loss of appetite.

So, what kind of medicine can you take with paroxetine hydrochloride tablets? Commodity name: paroxetine hydrochloride tablets (Leyou) drug interaction heart disease patients should generally pay attention to observe this product.

Epilepsy, like other psychiatric drugs, is used with caution in patients with epilepsy. Seizures In general, the incidence of seizures during treatment with this product is <%.

Patients with seizures should stop taking the drug.

Compared with other selective 5-HT reuptake inhibitors (SSRIs), glaucoma is less likely to cause dilated pupils, and glaucoma patients with narrowed angles should be used with caution. Children and adolescents (age less than 18 years of age) In children and adolescents with major depressive disorder and other mental illnesses, increased risk of suicidal ideation and behavior is associated with treatment with antidepressants. In the clinical trials of children and adolescents in this product, the signs of suicide (suicide attempts and suicidal thoughts) and hostility (mainly aggressive, confrontational behavior and anger) were associated with paroxetine-treated patients compared with placebo-treated patients. Adverse events are more common (see [Adverse Reactions].

There is currently no long-term safety profile for the growth, maturation, cognition and behavioral development of children and adolescents. Deterioration of clinical conditions and suicide risk in adults Young adults, especially young adults with major depressive disorder, may increase the risk of suicidal behavior during treatment with paroxetine.

A comparison of placebo-controlled trials in adults with psychiatric disorders showed that young adults treated with paroxetine (predefined age range 18-24 years) had higher rates of suicidal behavior compared with placebo. (17/776 [%] vs. 5/542 [%]), although this difference was not statistically significant. In the older age group (25-64 years old, and equal to or greater than 65 years old), no such increase was observed.

Adults with major depressive disorder (all ages) were treated with paroxetine, and the incidence of suicidal behavior was statistically significant compared with placebo (11/3455 [%] vs 1/978 [%] All events are suicide attempts). However, most of the (8/11) suicide attempts due to paroxetine occurred in young adults between the ages of 18 and 30.

These data for major depressive disorder indicate that the higher probability of suicide observed in a young adult population with mental illness may extend to people over 24 years of age. People with depression, whether taking antidepressants or not, may experience deteriorating depressive symptoms, and/or suicidal ideation and suicidal behavior (signs of suicide), which persists until the condition is significantly relieved.

Suicide risk may increase in the early stages of recovery, which is a common clinical experience for all antidepressant medications. Other psychiatric disorders treated with paroxetine may also have an increased risk of suicidal behavior, and these conditions may also be associated with major depressive disorder.

In addition, patients with suicidal behaviors or suicidal thoughts, young adults, and patients who showed significant suicidal ideation before starting treatment had a higher risk of suicidal thoughts or suicide attempts.

All patients should be monitored throughout the treatment period to see if there is clinical deterioration (including new symptoms) and signs of suicide, especially at the beginning of the treatment, or when changing the dose (increasing or decreasing).

Patients (and patient caregivers) should be warned to monitor for worsening of the condition (including new symptoms) and/or suicidal thoughts/behavior or self-injury. Once these symptoms occur, seek immediate medical advice. . It should be recognized that the appearance of some symptoms (such as excitement, meditation or mania) may be related to underlying disease states or medications (see sedation, mania, and bipolar disorder; [adverse reactions]. If the patient has clinical deterioration ( Including new symptoms, and/or suicidal thoughts/behaviors, especially those that are severe, sudden or new, should be considered for a change in treatment options, including possible discontinuation of the drug.

Electroconvulsive therapy (ECT) has no clinical experience with this product and electroconvulsive combination therapy.

However, rare patients taking SSRIs may have been reported to extend ECT-induced seizures and/or secondary epilepsy. Reports of rare hyponatremia with hyponatremia, mainly in elderly patients.

Symptoms of hyponatremia are usually reversed after discontinuation of the drug.

Bleeding has reported skin and mucous membrane bleeding (including gastrointestinal bleeding) after taking this product, so caution should be exercised with drugs that increase the risk of bleeding. Patients who are known and may have bleeding tendency should use this product with caution. . Monoamine oxidase inhibitors should be discontinued after treatment with monoamine oxidase (MAO) inhibitors for at least 2 weeks before paclitaxel can be used cautiously, and the dose of this product should be gradually increased until the desired effect is achieved (see [Contraindications] and [Drug Interactions] 銆?. Renal damage/hepatic damage should be used with caution in patients with severe renal impairment or liver damage (see [Usage and Dosage]). The clinical experience of driving/manipulating the machine proves that after taking this product, it has no effect on cognitive or psychomotor function. However, like all elite active drugs, patients taking medication should be cautious when driving or operating the machine. Symptoms of discontinuation of paroxetine in adults: In adult clinical trials, 30% of patients treated with paroxetine had adverse events and 20% of patients in the placebo group had adverse events.

The occurrence of withdrawal symptoms is different from the symptoms of drug addiction or drug dependence in substance abuse. Dizziness, sensory disturbances (including paresthesia, electroconvulsive sensation and tinnitus), sleep disorders (including strong dreams), excitement or anxiety, nausea, tremors, confusion, sweating, headache, and diarrhea have been reported. These symptoms are generally mild to moderate, but some patients may have more severe symptoms.

These conditions often occur a few days after discontinuation of the drug, but it is also rare to report that these symptoms occur in patients who accidentally missed a drug.

These symptoms are generally self-limiting and often resolve within 2 weeks, although some people may have longer symptoms (2-3 months or longer). Therefore, it is recommended that when this product is deactivated, the drug should be gradually reduced according to the needs of the patient within a few weeks or months (see 'Paroxetine discontinuation', [Usage and Dosage]).

Symptoms of discontinuation of paroxetine in children and adolescents: In clinical trials in children and adolescents, 32% of patients treated with paroxetine had adverse events and 24% of patients in the placebo group had adverse events.

The rate of reported discontinuation of this product is at least 2% of the patient, and the incidence of at least 2 times the placebo group includes: emotional instability (including suicidal ideation, suicide attempt, mood change and tearing), neuroticism, Dizziness, nausea and abdominal pain (see [adverse reactions]).

[Specifications and Models] 20mg*14s (Leyou) [Precautions] 1. This product should generally be observed when using this product.

2. As with other psychiatric drugs, patients with epilepsy should be used with caution.

3. It is not advisable to drive a vehicle, operate machinery or work at height during medication. See the package instructions for details.

{娈佃惤}


Copyright Notice:Original article of this site, in2018/07/21 casino barriere blotzheim,由 Publish。

Please indicate:casino barriere blotzheim:http://en.hengzhongyuanlin.com/Seventeen/casino_barriere_blotzheim/

casino barriere blotzheim 娈佃 Main ingredient

More